![Jesper Høiland](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jesper Høiland
Vorsitzender bei
SCIBASE HOLDING AB (PUBL)
Vermögen: 41 000 $ am 31.05.2026
Profil
Jesper Høiland is currently Chairman at SciBase Holding AB since 2024, Independent Director at Allarity Therapeutics, Inc. starting 2025, Director at ALK-Abello A, and Head-Strategy at Rani Therapeutics Holdings, Inc. beginning 2026.
Former positions include President, Chief Executive Officer & Director at Radius Health, Inc. from 2017 to 2020; Independent Director at Concert Pharmaceuticals, Inc.; Director at LEO Pharma A; Director at Pharmaceutical Research & Manufacturers of America from 2014 to 2016; Senior Vice President-International Operations at Novo Nordisk A from 2004 to 2012; President at Novo Nordisk, Inc. from 2013 to 2017; Global Chief Commercial Officer & Senior VP at Ascendis Pharma A from 2020 to 2022; Management Consultant at Liseberg AB from 1985 to 1987; General Manager at Novo Nordisk Pharmaceuticals Pty Ltd.; and Senior Vice President at Novo Nordisk North America, Inc. Education includes a graduate degree from Copenhagen Business School conferred in 1985.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 07.01.2026 | 25.000 ( 0,16 % ) | 41 000 $ | 31.05.2026 |
Aktive Positionen von Jesper Høiland
| Unternehmen | Position | Beginn |
|---|---|---|
| ALK-ABELLÓ A/S | Direktor/Vorstandsmitglied | - |
| SCIBASE HOLDING AB (PUBL) | Vorsitzender | 13.06.2024 |
| ALLARITY THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 30.06.2025 |
| RANI THERAPEUTICS HOLDINGS, INC. | Corporate Officer/Principal | 25.03.2026 |
Ehemalige bekannte Positionen von Jesper Høiland
| Unternehmen | Position | Ende |
|---|---|---|
| ASCENDIS PHARMA A/S | Corporate Officer/Principal | 23.05.2022 |
| RADIUS HEALTH, INC. | Vorstandsvorsitzender | 28.04.2020 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Präsident | 01.03.2017 |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Direktor/Vorstandsmitglied | 01.01.2016 |
| NOVO NORDISK A/S | Corporate Officer/Principal | 01.01.2012 |
Ausbildung von Jesper Høiland
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
64
Beziehungen ersten Grades
15
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Concert Pharmaceuticals, Inc.
 Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel medicines | Health Technology |
ALK-Abello A/S
 ALK-Abello A/S Pharmaceuticals: MajorHealth Technology Develops and produces, markets products for diagnosing, treating allergies, allergic asthma & acute anaphylactic reactions | Health Technology |
Copenhagen Business School
 Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LEO Pharma A/S
 LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Health Services |
SciBase Holding AB
 SciBase Holding AB Medical SpecialtiesHealth Technology Develops point of care device for the detection of malignant melanoma | Health Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Develops biological medicines | Health Technology |
Ascendis Pharma A/S
 Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
Novo Nordisk North America, Inc. | |
Liseberg AB | |
Novo Nordisk Pharmaceuticals Pty Ltd.
 Novo Nordisk Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for diabetes care | Health Technology |
Allarity Therapeutics, Inc.
 Allarity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics | Health Technology |
Rani Therapeutics Holdings, Inc.
 Rani Therapeutics Holdings, Inc. BiotechnologyHealth Technology Engages in research and development of orally administered biological products | Health Technology |
